Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

A Multicenter Study to Evaluate Cardiovascular Risk Factors and Receipt of Primary and Preventive Care in Prostate Cancer Patients Who Receive Definitive Radiation Therapy and Androgen Deprivation Therapy.

This study will evaluate the proportion of prostate cancer patients receiving external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT) with controlled blood sugars (fasting glucose and hemoglobin A1c), blood pressure, and cholesterol profile (total cholesterol, LDL, HDL, triglycerides) at baseline, 3 months, and 12 months after completing radiation treatment. In addition, receipt of guideline-recommended cardiovascular, primary and preventive care as well as patient-reported quality of life and satisfaction with care among these patients will be evaluated at baseline and 12 months.

Inclusion Criteria:

• Histologically-confirmed, non-metastatic prostate cancer
• Patients who will receive external beam radiation treatment with androgen deprivation therapy (total ADT duration > 3 months) for curative treatment, either in the definitive or post-prostatectomy setting
• Patients who have a primary care provider
• Informed consent obtained and signed
• Ability to read and write English
• Age >= 18
• No mental incompetence which would preclude completion of questionnaires

Exclusion Criteria:

• Prior cancer, pelvic radiation treatment or chemotherapy
• Patients who do not have a primary care provider
• Prior ADT
• Mental incompetence which would preclude completion of questionnaires
• Unable to read and write English